FFA
NBIX icon

Frazier Financial Advisors’s Neurocrine Biosciences NBIX Stock Holding History

Frazier Financial Advisors’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.22K Hold
70
– – 0.01% 423
2025
Q4 		$9.93K Hold
70
– – 0.01% 359
2025
Q3 		$9.83K Hold
70
– – 0.01% 355
2025
Q2 		$8.8K Hold
70
– – 0.01% 367
2025
Q1 		$7.74K Hold
70
– – 0.01% 370
2024
Q4 		$9.6K Hold
70
– – 0.01% 347
2024
Q3 		$8.07K Hold
70
– – 0.01% 416
2024
Q2 		$9.64K Hold
70
– – 0.01% 447
2024
Q1 		$9.65K Hold
70
– – 0.01% 419
2023
Q4 		$9.22K Buy
+70
New +$8.06K 0.01% 362

Other funds holding NBIX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return